Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Psychopharmacology
|
January 1, 1992
A placebo controlled trial of remoxipride in the prevention of relapse in chronic schizophrenia
D J King, M Blomqvist, S J Cooper, et al.
Anesthesia and Analgesia
|
December 1, 1996
Biphasic drug absorption from the epidural space of the dog may limit the utility of a slow release medium molecular weight hyaluronic acid-lidocaine ionic complex formulation
M M Doherty, P J Hughes, S A Charman, et al.
American Journal of Respiratory Cell and Molecular Biology
|
February 1, 1996
Mucin production by SPOC1 cells--an immortalized rat tracheal epithelial cell line
S H Randell, J Y Liu, P C Ferriola, et al.
American Journal of Respiratory Cell and Molecular Biology
|
April 1, 1995
Phenotype and differentiation potential of a novel rat tracheal epithelial cell line
M M Doherty, J Liu, S H Randell, et al.
The American Journal of Gastroenterology
|
April 1, 1995
Hepatic encephalopathy after transjugular intrahepatic portosystemic shunts: incidence and risk factors
K A Somberg, J L Riegler, J M LaBerge, et al.
Radiology
|
February 1, 1993
Transjugular intrahepatic portosystemic shunts in patients with portal vein occlusion
P M Radosevich, E J Ring, J M LaBerge, et al.
Radiology
|
December 1, 1992
Role of parallel transjugular intrahepatic portosystemic shunts in patients with persistent portal hypertension
Z J Haskal, E J Ring, J M LaBerge, et al.
Radiology
|
May 1, 1993
Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients
J M LaBerge, E J Ring, R L Gordon, et al.
Journal of Vascular Surgery
|
August 1, 1992
Transjugular intrahepatic portosystemic shunts: preliminary results in 25 patients
J M LaBerge, E J Ring, J R Lake, et al.
Biochemical Pharmacology
|
March 9, 2006
Preclinical analysis of the analinoquinazoline AG1478, a specific small molecule inhibitor of EGF receptor tyrosine kinase
A G Ellis, M M Doherty, F Walker, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Psychopharmacology
|
January 1, 1992
A placebo controlled trial of remoxipride in the prevention of relapse in chronic schizophrenia
D J King, M Blomqvist, S J Cooper, et al.
Anesthesia and Analgesia
|
December 1, 1996
Biphasic drug absorption from the epidural space of the dog may limit the utility of a slow release medium molecular weight hyaluronic acid-lidocaine ionic complex formulation
M M Doherty, P J Hughes, S A Charman, et al.
American Journal of Respiratory Cell and Molecular Biology
|
February 1, 1996
Mucin production by SPOC1 cells--an immortalized rat tracheal epithelial cell line
S H Randell, J Y Liu, P C Ferriola, et al.
American Journal of Respiratory Cell and Molecular Biology
|
April 1, 1995
Phenotype and differentiation potential of a novel rat tracheal epithelial cell line
M M Doherty, J Liu, S H Randell, et al.
The American Journal of Gastroenterology
|
April 1, 1995
Hepatic encephalopathy after transjugular intrahepatic portosystemic shunts: incidence and risk factors
K A Somberg, J L Riegler, J M LaBerge, et al.
Radiology
|
February 1, 1993
Transjugular intrahepatic portosystemic shunts in patients with portal vein occlusion
P M Radosevich, E J Ring, J M LaBerge, et al.
Radiology
|
December 1, 1992
Role of parallel transjugular intrahepatic portosystemic shunts in patients with persistent portal hypertension
Z J Haskal, E J Ring, J M LaBerge, et al.
Radiology
|
May 1, 1993
Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients
J M LaBerge, E J Ring, R L Gordon, et al.
Journal of Vascular Surgery
|
August 1, 1992
Transjugular intrahepatic portosystemic shunts: preliminary results in 25 patients
J M LaBerge, E J Ring, J R Lake, et al.
Biochemical Pharmacology
|
March 9, 2006
Preclinical analysis of the analinoquinazoline AG1478, a specific small molecule inhibitor of EGF receptor tyrosine kinase
A G Ellis, M M Doherty, F Walker, et al.
Page
of 2